Top Mover
Northrop Grumman Shares Drop 4% After Losing Navy F/A-XX Fighter Jet Contract to Boeing
Read this in the Market Flux appNorthrop Grumman Corporation $NOC
$483.42-4.26%as of publication
- 5D Change
- -6.05%
- Market Cap
- $71.69B
Northrop Grumman fell sharply on September 30 after the Pentagon and White House announced that Boeing had won the contract to develop and build the U.S. Navy's next-generation F/A-XX Strike Fighter, a stealthy sixth-generation jet intended to replace the Navy's fleet of F/A-18 Super Hornets. The contract is valued at more than $20 billion, making it one of the most significant defense awards in recent memory.
Northrop Grumman shares dropped approximately 4.3% in premarket trading and continued sliding through the session, with the stock appearing among the day's notable movers. Boeing, by contrast, rose more than 3% on the news, one of the sharper single-day gains in the defense sector on the day, as the win offered a meaningful boost to a company that has endured years of operational and financial strain.
The F/A-XX program, still classified, represents the Navy's Top Gun-era successor aircraft and carries long-term production implications well beyond the initial contract value. Analysts at Investing.com examined the contract loss and its impact on Northrop's outlook, with the defeat removing a major prospective revenue stream from the company's pipeline.
© AI-generated summary is provided by Market Flux
Sources
- StaunovoBoeing beat Northrop Grumman to produce the Navy’s next Top Gun fighter jet, the stealthy and still classified F/A-XX, the Pentagon/White House announced today
- ZerohedgePremarket movers: Mag 7 stocks are mixed: Alphabet +1%, Nvidia +0.1%, Amazon -0.2%, Apple little changed, Tesla -0.8%, Microsoft -0.1%, Meta Platforms -1% Achieve Life Sciences (ACHV) gains 3% after Stifel initiated coverage with a buy recommendation, citing a “potential blockbuster opportunity” for the biotech firm’s smoking-cessation drug candidate. Boeing (BA) rises 2% after the company beat Northrop Grumman Corp to produce the Navy’s next Top Gun fighter jet. Northrop (NOC) falls 4.3%. Cal-Maine (CALM) falls 6% after the egg producer reported net sales for the first quarter that missed the average analyst estimate, and said it won’t pay a cash dividend in the first quarter. Concentrix (CNXC) is down 9% after the call-center operator forecast fourth quarter revenue below expectations amid investor concerns that the business could come under pressure from AI-assisted automation tools. FactSet (FDS) falls 2% after the financial-data provider gave a 2027 earnings per share forecast that missed the average analyst estimate. GameStop (GME) gains 1% after a filing showed that Chairman and CEO Ryan Cohen purchased $10.6 million worth of shares. Moderna (MRNA) declines 6% after Citi downgraded the vaccinemaker to sell, saying optimism from its recent oncology success is more than priced in the stock’s outsized rally. Robinhood (HOOD) rises 2% after the brokerage launches new products that help users utilize AI agents to build and execute trading strategies. It’s also allowing customers to trade perpetual futures on some cryptocurrencies. Vanda Pharmaceuticals (VNDA) rises 4% after the drugmaker said its drug Hetlioz met its primary endpoint in a late-stage trial for adults with Delayed Sleep-Wake Phase Disorder — a circadian rhythm sleep disorder (source: BBG)
- InvestingWhy is Northrop Grumman stock sliding today?